Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Watch Best of BIO
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Addressing Climate Change
    Strengthening the Bioeconomy
    Growing Trust in Innovation
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    Learn More >
  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO International Convention

    June 5-8, 2023 | Boston, MA
    Stand up for innovation. Stand up for truth. And stand up for science. 

    Learn more
    Teal Box Mega Nav
    BIO-Europe Spring

    March 20-22, 2023 | Basel, CH
     

    Teal Box Mega Nav
    BIO Asia-Taiwan

    July 27-30, 2023 | Taipei, TW

     

    Teal Box Mega Nav
    BIO Impact Ag & Environment Conference

    September 19-20, 2023 | Raleigh, NC

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • BIO Media
    BIO Media

    Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.

    I am BIO Podcast
    Good Day BIO Newsletter
    I am BIO Video
    Join Today
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
683 Results Found

Covid Vaccine
Anti-vaccine legislation is expected to increase in 2022
As the world contends with the rapidly spreading Omicron variant of COVID-19, getting more people vaccinated and boosted is all the more essential. Unfortunately, however, many state legislatures have presented a slew of anti-vaccine legislation—and this seems unlikely to change in 2022. "Over 1…

U.S. Capitol Dome
What to expect from the 117th Congress
With the new Congress comes new priorities that are in large part dictated by the leadership in both the U.S. House of Representatives and the Senate. At the top of the agenda is confronting the COVID-19 pandemic, including passing the $1.9 trillion relief package being proposed by the Biden…

Biden and Harris
What to expect during the Biden administration’s first 100 days
This week marked the beginning of a new era in U.S. politics with the inauguration of President Joe Biden and Vice President Kamala Harris. In his inauguration speech, President Biden made it clear that confronting COVID-19 is a priority of his administration, stating, “We must set aside the…

Jeremy Levin
Challenges and Opportunities in the Biotech Industry in 2020
The 22nd annual BIO CEO & Investor Forum kicked off today with a Welcome and Update on BIO's 2020 Initiatives on Behalf of the Industry given by Jeremy Levin, CEO of Ovid Therapeutics Chair of the Board of Directors of BIO. The industry was established in 1970’s during an era of bipartisan…

Patient at Pharmacy
CMS’s Own Data Do NOT Support Claims on Part B Drug Spending
In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for Politico Pulse note: “The agency [Centers for Medicare & Medicaid Services] on Friday announced a $9 monthly premium increase and $13 annual deductible hike, but argued that the White House is working to bring…

U.S. Capitol Dome
In Speaker Pelosi’s Extreme Drug Pricing Bill, Funding for NIH is MIA
Supporters of Speaker Pelosi’s extreme drug pricing bill (H.R. 3) want us to believe that they can destroy the biopharmaceutical industry and still produce new cures and treatments for patients in need. The crux of this fairy tale is the promise by supporters of H.R. 3 to reinvest “savings” from…

Prescription Doctor
The Pelosi Plan and "Me Too" Drugs
Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the development of so-called “me too” drugs. For example, Rep. Donna Shalala was recently quoted as saying:  “I think it actually will reduce me-too drugs … I think [pharmaceutical companies] are going to…

Patient & Health Advocacy Summit
#BIOSummit19 Concludes with Message of Hope Offered by Innovation
Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) came together to proclaim: “I am BIO.” But as Dr. Julie Gerberding, executive vice president and chief patent officer at Merck and Co., who acted as the event…

Patient & Health Advocacy Summit
FDA Discusses Effective Patient Engagement at #BIOSummit19
For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part of the drug development and review process. However, how that engagement happens can determine how successful it is. This was the key question addressed by the “Practices and Principles: Navigating…

BIO Logo
BIO's Leadership Transition | "The fight continues..."
On Tuesday, October 8, BIO formally announced that its President and CEO Jim Greenwood would be stepping down from the world's largest biotechnology organization in January 2021. In a letter to BIO staff, Greenwood reflected on his rise to BIO and the accomplishments the organization has achieved…

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • ›› Next page
  • Last » Last page
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Impact Ag & Environment Conference
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO DOUBLE HELIX SPONSORS
Sanofi logo
Amgen logo
Bristol Myers Squibb
Genentech logo
Merck_logo_2022
BIO HELIX SPONSORS
Pfizer Inc Logo
Eli Lilly and Company
AbbVie Logo
Johnson and Johnson
Travere logo
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO